Business · 1 sources covering this

Semaglutide mkt settles into steady growth six months after patent expiry

Generic brands now account for about 74% of monthly units as lower-priced products expand access, while doctors say the initial rush around the drug is cooling

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

Business StandardCenter·2h ago
Semaglutide mkt settles into steady growth six months after patent expiry
Generic brands now account for about 74% of monthly units as lower-priced products expand access, while doctors say the initial rush around the drug is cooling
Read at Business Standard →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/c0b4efb11fbcbb4e6f24166c200497bd64eb993e"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Semaglutide mkt settles into steady growth six months after patent expiry"></iframe>

Semaglutide mkt settles into steady growth six months after patent expiry

How 1 sources are covering this

Semaglutide mkt settles into steady growth six months after patent expiry

More from Business

Why is BMC proposing a hike in public toilet charges? Here are charges that Mumbaikars can face

Rupee jumps 40 paise to close at 95.38 against U.S. dollar

Mohanlal congratulates Ajay Devgn after Drishyam 3 crosses 300 cr in India

India offers reliability, stability amid global uncertainty: PM Modi

Reader

Trust & legal

Across the network